HLHsiang-Yuan Lin

Hsiang-Yuan Lin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Hsiang-Yuan Lin has a total of 153 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Limited evidence for non-invasive brain stimulation as a cognitive enhancer in neurodevelopmental disorders: A multilevel meta-analysis of sham-controlled trials

    by Jiangbo Ying, Pushpal Desarkar, Terri Rodak, Veronica Yan Kiu Yu, Vivian Liang, Joanna Sie, Stephanie H. Ameis, Tarek K. Rajji, Hsing-Chang Ni, Hsiang-Yuan Lin

  • Open Access

    Menstrual-Cycle Modulation of Striato-Pallidal Reward Reactivity to Nicotine-Product Cues in Exclusive E-Cigarette Users: A Pilot Study

    by Laurie Zawertailo, Marium Ali, Hsiang-Yuan Lin

    Ovarian hormones modulate reward-related circuitry implicated in nicotine dependence, yet the neural mechanisms linking menstrual-cycle phase to nicotine cue reactivity remain poorly understood. These effects have not previously been examined in exclusive e-cigarette users, who are exposed to fewer but different toxicants than smokers. Using a within-subject, hormone-verified fMRI design, 19 naturally cycling exclusive nicotine-vaping women (aged 18–30) completed a cue-reactivity task (vaping, smoking, and neutral cues) during late-follicular (FP) and mid-luteal (LP) phases. Menstrual cycle phase was verified by a within-person FP-to-LP rise in urinary pregnanediol glucuronide (PdG LP>FP: t(18)=3.38, p=0.003). Smoking cues provided an alternative nicotine-product cue category, so the Vaping>Smoking contrast tested preferred versus non-preferred cues. Vaping>Smoking activation was greater in FP than LP across six clusters surviving voxelwise p<0.001 with cluster-level familywise-error (FWE) correction: right pallidum/ventral striatum (k=875, [16,2,0], p=0.001), left lingual and occipital cortex, right superior parietal lobule, and two right frontal clusters. The contrast also survived threshold-free cluster enhancement (5 000 permutations, FWE p<0.05). The peak localized primarily to the right pallidum (~91%), within an a priori striato-pallidal reward mask; a separate dorsal-putamen ROI showed the effect at [22,2,2] (p=0.020). In-scanner smoking-cue craving was lower in FP (t(18)=−2.30, p=0.034, d=−0.53). Vaping cues engaged the nucleus accumbens versus neutral within an a priori accumbens region (SVC p=0.004). Direct hormone regressions, dependence analyses, and phase- or hormone-modulated connectivity showed no corrected effects. These findings identify menstrual-cycle modulation of striato-pallidal reward reactivity as a candidate substrate of sex-related variability in nicotine-cue processing in exclusive vapers.

  • Open Access

    Factors linked to successful brain magnetic resonance imaging scans and data quality in autistic individuals across the functioning spectrum

    by Lin-Wan Huang, Yi Ran Zhou, Chun-Hung Yeh, Hsing-Chang Ni, Benoit H. Mulsant, Muhammad Ishrat Husain, Jung-Chi Chang, En-Nien Tu, Mei-Yun Hsu, Yu-Yu Wu, et al.

    Background: Neuroimaging research in autism often excludes individuals with co-occurring intellectual impairment or minimally verbal status, limiting the generalisability of findings. Understanding magnetic resonance imaging (MRI) scan success predictors in a representative autistic sample is crucial for equitable research. Aims: This study identified factors predicting successful brain MRI acquisition and data quality in diverse autistic individuals, focusing on including those with intellectual impairment or minimally verbal status. Method: A total of 122 participants (83 autistic individuals (27 with intellectual impairment, 19 with minimally verbal status) and 39 typically developing controls) received multi-modal brain MRI scans (including structural, resting-state functional and diffusion MRI). Scan success, assessed using both binary criteria and quantitative data-quality metrics, was related to participant characteristics. Results: Although overall scan success was high, specific factors differentiated success within subgroups. Key factors contributing to scan success included age, non-verbal intelligence and attention-deficit hyperactivity disorder (ADHD) symptoms. Older participants, those with fewer ADHD symptoms and those with higher non-verbal intelligence were more likely to achieve successful scans, regardless of autism diagnosis. Higher data quality, particularly in structural and functional MRI, was associated with higher intelligence, better adaptive functioning, fewer autistic and ADHD symptoms, and fewer behavioural problems. Conclusions: Identifying these factors is key to designing more inclusive and effective neuroimaging protocols. This work paves the way for more comprehensive research into the neurobiology of the full autism spectrum, and offers insights for improving the clinical MRI experience for autistic individuals with diverse support needs. Individualised strategies may also be useful in clinical settings, helping to improve the experience of MRI scanning for autistic individuals.

  • Open Access

    Beyond the Outburst: Charting a New Frontier for Understanding and Treating Irritability in Autistic Adults

    by Hsiang‐Yuan Lin, Arthur N. Westover, Amy S. F. Lutz, Manish K. Jha

    Irritability is a prevalent and impairing feature associated with autism, yet remains poorly understood, particularly in adults. Drawing heavily on insights translated from pediatric and transdiagnostic literatures, we propose that irritability in autistic individuals often reflects a psychophysiological stress or threat response, rooted in a vulnerable neurobiology (e.g., sensory sensitivities, intolerance of uncertainty), but may also stem from intrinsic neurobiological dysregulation independent of environmental triggers. The current treatment paradigm for autistic adults, largely extrapolated from pediatric antipsychotic trials, leaves these adults critically underserved due to a lack of evidence‐based treatments, clinical trials, or validated tools to measure their internal experience. This viewpoint deconstructs irritability, differentiating its affective nature from aggression, and highlights heterogeneity across the lifespan and support needs. We critique the limitations of current assessment methods and recommend a shift toward a multi‐modal strategy integrating self‐report (when feasible) with objective, physiologically‐informed tools (e.g., wearable biosensors) and nuanced observer reports. We argue that the field is poised for neuroscience‐informed treatment innovation—including novel pharmacological agents and adapted psychosocial interventions—but is hampered by a lack of rigorous clinical trials in adults. Finally, we call for mechanistically driven trials to address the large unmet burden of inadequately treated irritability, ultimately improving the quality of life for autistic adults and their families/caregivers.

  • Open Access

    Brain idiosyncrasy during biological-motion perception is amplified in autistic individuals with intellectual impairment

    by Michael Cheng, Colin Hawco, Daniel Yang, Hsing-Chang Ni, Chun-Hung Yeh, Jung-Chi Chang, En-Nien Tu, Mei-Yun Hsu, Yu-Yu Wu, Tai-Li Chou, et al.

    Background: Neuroimaging research in autism spectrum condition (ASC) often overlooks brain idiosyncrasy by focusing on group averages and frequently excludes individuals with co-occurring intellectual impairment (II). Methods: We investigated functional MRI correlates of passive biological motion (BM) perception, comparing typically developing controls (TDC; n = 33), autistic individuals without II (intellectually able; ASC-IA; n = 28), and autistic individuals with II (ASC-II; n = 19; defined by IQ or adaptive function < 85). Results: While standard group-average analyses revealed the expected BM-sensitive regions (e.g., bilateral posterior superior temporal sulci, cuneus) in the TDC and ASC-IA groups, the ASC-II group showed no consistent group-level activation pattern and exhibited greater activation in the right intraparietal sulcus compared to the ASC-IA group. Using a correlational distance-based metric, we quantified brain idiosyncrasy (“whole-sample brain variability”, Variability Whole ), representing the deviance of an individual's activation pattern from others. Brain activity in the ASC-II group was significantly more idiosyncratic than the ASC-IA and TDC groups. Furthermore, Variability Whole showed significant transdiagnostic correlations with multiple cognitive and behavioural domains relevant to autism, including social difficulties, repetitive behaviours, non-verbal IQ, executive function, sensory hyper/hyposensitivity, ADHD symptoms, and adaptive function. Conclusions: Key limitations include the cross-sectional design and the use of a passive viewing task without a concurrent behavioral measure to directly link brain findings to task performance. These findings highlight substantial brain heterogeneity within the autism spectrum, particularly in the understudied ASC-II subgroup, and suggest that individual differences in brain processing patterns, rather than solely group-average differences, are critically linked to clinical and cognitive phenotypes.

  • Open Access

    Publisher Correction: From heterogeneity to idiosyncrasy in the autistic brain

    by Hsiang-Yuan Lin, Michael Breakspear, Laurent Mottron

  • Top Cited Papers

    From heterogeneity to idiosyncrasy in the autistic brain

    by Hsiang-Yuan Lin, Michael Breakspear, Laurent Mottron


  • The conceptual landscape of self-regulation in neurodevelopmental conditions: an overview of reviews

    by Iciar Iturmendi-Sabater, Sejal Jain, Sofia Turcany-Diaz, Reena Besa, Evdokia Anagnostou, Marc A. Fournier, Hsiang-Yuan Lin, Meng-Chuan Lai

    Self-regulation is critical yet inconsistently defined across neurodevelopmental conditions (NDCs). This preregistered (CRD42023350582), PRISMA-aligned overview of reviews aimed to (1) review and summarize definitions and models of self-regulation, (2) synthesize key self-regulation-related constructs and (3) identify common self-regulation measures in NDC populations. We searched Ovid Medline/PsycINFO/Embase, Web of Science—Core Collection and Cochrane Databases (inception to September 2024). We included 35 narrative, 2 scoping, 7 systematic and 3 meta-analytic peer-reviewed reviews of human studies on autism, attention-deficit/hyperactivity disorder and intellectual disability that addressed self-regulation across emotional, cognitive and behavioural domains. We found that, despite varied terminology, elevated dysregulation was consistently reported across the included reviews. Inductive content analysis of the included reviews identified core psychological constructs related to self-regulation and their developmental and environmental-contextual interplays; the findings converged into a domain-general, transdiagnostic self-regulation framework emphasizing interdependent integration of emotional, cognitive and behavioural processes across contexts. Finally, a meta-summary from 332 primary empirical studies from the included scoping, systematic and meta-analytic reviews (69 autism, 130 intellectual disability and 133 attention-deficit/hyperactivity disorder) revealed measurement gaps with 521 identified measurements relying heavily on parent-report questionnaires. Risk of bias assessed through the Joanna Briggs Institute checklist revealed methodological heterogeneity. This overview of reviews offers guidance for aligning research, assessments and interventions with a domain-general, developmental understanding of self-regulation across NDCs.


  • Open Access

    Urban–Rural Differences and Sex‐Specific Cognitive Effects on Autism Symptom Trajectories: A Longitudinal Study of Autistic Children in Taiwan

    by Yun‐Ju Chen, Hsiang‐Yuan Lin, Ching‐Lin Chu, Chin‐Chin Wu, Tzu‐Ling Lin, Hsing‐Chang Ni, Jiun‐Horng Liu, Yuh‐Ming Hou, Chung‐Hsin Chiang

    Few longitudinal studies have mapped autism symptom trajectories outside Western contexts. This study aimed to characterize trajectories of autism symptoms, assessed using the Autism Diagnostic Observation Schedule (ADOS), and associated child and family factors among autistic children from two regions in Taiwan that differ by urbanicity. Another aim was to examine the time‐varying effects of children's cognitive abilities on autism symptoms, which remain understudied due to prior reliance on baseline proxies. Children with a confirmed autism diagnosis ( n = 180, 87.8% male) were followed across three waves of data collection from ages 2 to 11 years. Linear multilevel growth models with random intercepts and slopes were used to estimate symptom trajectories at the total and domain levels of the ADOS. On average, total and social‐affect symptoms increased significantly with age, while restricted and repetitive behaviors (RRBs) remained stable. Children from urban areas showed higher baseline RRBs and smaller increases in social‐affect symptoms compared to those from rural areas. Additionally, children diagnosed under DSM‐5 criteria showed lower baseline symptoms but greater increases in total/social‐affect symptoms over time than their DSM‐IV counterparts. A sex interaction effect was observed in the time‐varying associations between IQ (particularly verbal IQ) and total/social‐affect symptoms, with girls showing stronger negative IQ‐symptom associations. These findings highlight the developmental complexity underlying the manifestation of autism symptoms, particularly at the intersection of sex and cognition. The distinct patterns by urbanicity also underscore the need to mitigate urban–rural disparities in service access to better support autistic children's long‐term outcomes.

  • Open Access

    Knowledge, perceptions, and use of psychedelics for mental health among autistic adults: An online survey

    by Sahba Afsharnia, Vivian Liang, Yona Lunsky, Aaron P. Orsini, Ami Tint, Hsiang-Yuan Lin

    Psychedelics such as psilocybin, LSD, and MDMA have shown promise in treating mental health conditions (e.g., depression, post-traumatic stress disorder) among neurotypical individuals, i.e., typically developing individuals without a diagnosed neurodevelopmental condition. However, their therapeutic potential for treating co-occurring mental-health conditions in autistic individuals remains under-explored. Autistic individuals often face co-occurring mental health challenges but are frequently excluded from clinical trials, creating a gap in effective treatments. This study aimed to explore knowledge, perceptions, and experiences of autistic adults regarding psychedelics. In this survey, “psychedelics” included classical psychedelics such as psilocybin and LSD, as well as MDMA. A cross-sectional online survey was conducted with English-speaking autistic adults. We assessed participants’ knowledge of psychedelics, willingness to use them for mental health treatment, and any past psychedelic experiences. Data were analyzed using descriptive statistics and chi-square tests to assess group differences. A total of 424 participants began the survey, with 261 completing it. Nearly half resided in Canada. Participants generally viewed psychedelics positively, with 77.8% expressing a willingness to try them, and 69.7% reported past use—most commonly psilocybin mushrooms. Higher doses and highly meaningful experiences correlated with longer-lasting mental health improvements. Barriers included legal concerns, health risks, and logistical challenges. Participants with prior experience reported greater perceived knowledge and lower perceived risks. Autistic adults in this self-selecting sample demonstrated strong interest in psychedelics as potential treatments for mental health, despite significant barriers to access and research participation. These results highlight the importance of considering education, policy reform, and inclusive research practices to ensure that autistic people have opportunities to explore psychedelic therapies. These findings should be interpreted cautiously, as the sample may not be representative of the broader autistic population. Future trials should optimize dosing and explore long-term benefits of psychedelics in this population.